Main Office 47906 West Lafayette , Indiana
3000 Kent Avenue Suite A1-10047906 West Lafayette , Indiana
Registration country:United States
Folate-based cancer and autoimmune disease therapies
We are a biopharmaceutical company developing targeted therapies for the treatment of cancer and other serious diseases. We use our proprietary technology to create novel small molecule drug conjugates or SMDCs, and companion imaging diagnostics. Our SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone.